Clinical Trials on Parathyroid Gland Atypical Adenoma

Total 1024 results

Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

Islet Cell Tumor | Gastrointestinal Carcinoid Tumor

United States
National Cancer Institute (NCI)

Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Metastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine Tumor

United States, Canada
Eunice Kennedy Shriver National Institute of Child...

Recruiting

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Cushing Disease | Prolactinoma | Panhypopituitarism | Gigantism/Acromegaly

United States
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Withdrawn

Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors

Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma
Cambridge University Hospitals NHS Foundation Trust

Completed

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Islet Cell Tumor | Gastrointestinal Carcinoid Tumor

United Kingdom
AbbVie (prior sponsor, Abbott)

Completed

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice (TOP)

Secondary Hyperparathyroidism | Kidney Insufficiency

Austria, Germany
Innovative Digestive Health Education and Research...
NinePoint Medical

Unknown

Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study (VLE-IOV)

Cholangiocarcinoma | Bile Duct Cancer | Primary Sclerosing Cholangitis | Bile Duct Diseases | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer | Bile Duct Neoplasms | Biliary Stricture | Bile Duct Obstruction | Bile Duct Obstruction, Extrahepatic | Pancreatic Duct Stricture | Bile Duct Lesions | Bile Duct Neoplasms... and other conditions

United States
Sheffield Teaching Hospitals NHS Foundation Trust
Novartis; Barts & The London NHS Trust; The Christie NHS Foundation Trust; Oxford...

Terminated

Pasireotide Therapy in Patients With Nelson's Syndrome

Nelson Syndrome

United Kingdom
Federal University of São Paulo

Completed

Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Hypogonadotropic Hypogonadism | Prolactinoma

Brazil
Hacettepe University
Hacettepe University, Faculty of Medicine

Completed

Exercise Capacity and Physical Activity Level in Prolactinoma Patients

Prolactinoma

Turkey
IRCCS San Raffaele

Not yet recruiting

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Pituitary Adenoma | Acromegaly | Hypopituitarism | Adiposity | Cushing Syndrome | Endocrine Disorders
Sparrow Pharmaceuticals

Active, not recruiting

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome (RESCUE)

Cortisol; Hypersecretion | Cortisol Overproduction | Cushing's Syndrome I | Cushing Disease Due to Increased ACTH Secretion | Cortisol Excess | Ectopic ACTH Secretion

United States, Bulgaria, Romania
Kyowa Kirin China Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

Hyperparathyroidism; Secondary, Renal

China
National Institute of Diabetes and Digestive and...

Completed

Cinacalcet to Treat Familial Primary Hyperparathyroidism

Hypercalcemia | Familial Primary Hyperparathyroidism

United States
Amgen

Completed

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Nephrology
Abbott

Completed

Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis

End Stage Renal Disease | Secondary Hyperparathyroidism

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor | Metastatic Malignant Neoplasm in the Liver | Stage I Pancreatic Neuroendocrine Tumor AJCC v8 | Stage II Pancreatic Neuroendocrine Tumor AJCC v8 | Stage III Pancreatic Neuroendocrine Tumor AJCC v8

United States
M.D. Anderson Cancer Center

Recruiting

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients

Multiple Endocrine Neoplasia

United States
Leiden University Medical Center

Terminated

Electrophysiology of the Human Pituitary Gland

Pituitary Adenoma | Pituitary Tumor | Diabetes Insipidus Cranial Type | Endocrine; Deficiency

Netherlands
National Cancer Institute (NCI)

Completed

Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

Locally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine Tumor

United States, Canada
M.D. Anderson Cancer Center

Active, not recruiting

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

Genetic Mutation | MEN1

United States
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Hyperparathyroidism | Hypovitaminosis D | Postmenopausal Osteoporosis

Mexico
Amgen

Completed

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

End Stage Renal Disease
Nabi Biopharmaceuticals

Completed

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

Arteriosclerosis | Hyperparathyroidism, Secondary | Calcinosis

United States
Zhebao Wu
Peking Union Medical College Hospital; Beijing Tiantan Hospital; Huashan Hospital and other collaborators

Unknown

Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

Invasive Prolactinomas Involving the Cavernous Sinus

China
AbbVie (prior sponsor, Abbott)

Completed

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience (PROTECT)

Secondary Hyperparathyroidism | Chronic Kidney Failure

Greece
Seoul National University Hospital

Recruiting

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) (SOLOMON)

Pituitary Adenoma | Meningioma | Schwannoma | Brain Tumor, Primary | Gliomas Benign

Korea, Republic of
Children's Hospital of Philadelphia

Available

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Insulinoma | Beckwith-Wiedemann Syndrome | Congenital Hyperinsulinism (CHI)

United States
Amgen

Terminated

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Chronic Kidney Disease | Hyperparathyroidism, Secondary

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
Amgen

Completed

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Hyperparathyroidism, Secondary

United States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D

Primary Hyperparathyroidism | Vitamin D Deficiency | Osteoporosis | Osteopenia | Hypercalcemia

United States
Clalit Health Services

Completed

Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density

Vitamin D Deficiency | Secondary Hyperparathyroidism | Osteomalacia

Israel
Mayo Clinic
Abbott

Completed

Oral Paricalcitol in Kidney Transplant Recipients

Hyperparathyroidism, Secondary | Renal Disease, End Stage | Transplant; Failure, Kidney

United States
Amgen

Completed

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Secondary Hyperparathyroidism | Chronic Renal Insufficiency
University of Milan

Completed

Vitamin D Supplementation in HIV-infected Youth

Hyperparathyroidism | Vitamin D Deficiency | Hypovitaminosis D | HIV Disease

Italy
Emory University
National Cancer Institute (NCI)

Recruiting

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (HiPPI)

Schwannoma | Grade III Meningioma | Intracranial Neoplasm | Nerve Sheath Neoplasm | Grade II Meningioma | Grade I Meningioma | Pituitary Gland Adenoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Lung Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome

United States
Abbott

Completed

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Secondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5

United States
Guangxi Medical University

Recruiting

EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor | Multiple Endocrine Neoplasia Type 1

China
University of California, San Francisco
Sanofi; Genentech, Inc.

Terminated

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Lung Cancer | Neuroendocrine Tumor | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome

United States
Yale University
National Cancer Institute (NCI)

Terminated

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Metastatic Cancer | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor

United States
Crinetics Pharmaceuticals Inc.

Recruiting

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Cushing Syndrome | Cushing Disease | Ectopic ACTH Syndrome

United States
Deltanoid Pharmaceuticals

Completed

A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis (2MD-7H-2B)

Kidney Failure, Chronic | Hyperparathyroidism, Secondary

United States
Amgen

Completed

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Korea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
Amgen

Completed

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary

United States, Germany, United Kingdom
Benha University
New Jeddah Clinic Hospital

Completed

Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

Diabetic Nephropathies | Secondary Hyperparathyroidism
The University of Hong Kong
AbbVie

Unknown

Intravenous Paricalcitol in Chronic Hemodialysis Patients

Secondary Hyperparathyroidism | Endstage Renal Disease

Hong Kong
AbbVie (prior sponsor, Abbott)

Completed

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous (QUALITIZE)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Greece
Abbott

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D (IMPACT SHPT)

Hemodialysis | Chronic Kidney Disease | Secondary Hyperparathyroidism

United States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom

Clinical Trials on Parathyroid Gland Atypical Adenoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations